Published in AIDS Weekly, December 4th, 2000
Workers in The New York Blood Center report that such efforts need to draw from a variety of sources and involve community agencies to be successful. They should know: 72% of the at-risk women they attempted to recruit to an HIV vaccine preparedness study rejected the opportunity to participate.
Pamela Brown-Peterside and colleagues enrolled at-risk, non-injection drug user, HIV-1 negative women into their study in the following ways:
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.